About MEAJO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions to authors | Online submission | Subscribe | Advertise | Contact | Login 
Middle East African Journal of Ophthalmology Middle East African Journal of Ophthalmology
Users Online: 108   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size

    Article Cited by others

REVIEW ARTICLE

Diabetic retinopathy and inflammation: Novel therapeutic targets

Rangasamy Sampathkumar, McGuire Paul G, Das Arup

Year : 2012| Volume: 19| Issue : 1 | Page no: 52-59

   This article has been cited by
 
1 Role of endocannabinoids in the progression of diabetic retinopathy
Tapan Behl,Ishneet Kaur,Anita Kotwani
Diabetes/Metabolism Research and Reviews. 2016; 32(3): 251
[Pubmed]  [Google Scholar] [DOI]
2 Effect of Intravitreal Injection of Methotrexate on Human Corneal Endothelial Cells
Khalil Ghasemi Falavarjani,Sara Golabi,Ali Hadavandkhani
Cornea. 2016; 35(2): 217
[Pubmed]  [Google Scholar] [DOI]
3 Proteome analysis of retinal glia cells-related inflammatory cytokines in the aqueous humour of diabetic patients
Stela Vujosevic,Alessandra Micera,Silvia Bini,Marianna Berton,Graziana Esposito,Edoardo Midena
Acta Ophthalmologica. 2016; 94(1): 56
[Pubmed]  [Google Scholar] [DOI]
4 Development of Diagnostic Biomarkers for Detecting Diabetic Retinopathy at Early Stages Using Quantitative Proteomics
Jonghwa Jin,Hophil Min,Sang Jin Kim,Sohee Oh,Kyunggon Kim,Hyeong Gon Yu,Taesung Park,Youngsoo Kim
Journal of Diabetes Research. 2016; 2016: 1
[Pubmed]  [Google Scholar] [DOI]
5 Increased intravitreal adenosine 5'-triphosphate, adenosine 5'-diphosphate and adenosine 5'-monophosphate levels in patients with proliferative diabetic retinopathy
Sirpa Loukovaara,Sari Sahanne,Sirpa Jalkanen,Gennady G. Yegutkin
Acta Ophthalmologica. 2015; 93(1): 67
[Pubmed]  [Google Scholar] [DOI]
6 Puerarin suppresses high glucose-induced MCP-1 expression via modulating histone methylation in cultured endothelial cells
Peng Han,Dehong Gao,Wei Zhang,Suhuan Liu,Shuyu Yang,Xuejun Li
Life Sciences. 2015; 130: 103
[Pubmed]  [Google Scholar] [DOI]
7 Efficacy and vitreous levels of topical NSAIDs
Francesco Semeraro,Andrea Russo,Elena Gambicorti,Sarah Duse,Francesco Morescalchi,Sara Vezzoli,Ciro Costagliola
Expert Opinion on Drug Delivery. 2015; 12(11): 1767
[Pubmed]  [Google Scholar] [DOI]
8 Intravitreal Triamcinolone Acetonide in the Treatment of Ophthalmic Inflammatory Diseases with Macular Edema: A Meta-Analysis Study
Claudio Bucolo,Giuseppe Grosso,Valentina Drago,Caterina Gagliano
Journal of Ocular Pharmacology and Therapeutics. 2015; 31(4): 228
[Pubmed]  [Google Scholar] [DOI]
9 Diabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets
Arup Das,Paul G. McGuire,Sampathkumar Rangasamy
Ophthalmology. 2015; 122(7): 1375
[Pubmed]  [Google Scholar] [DOI]
10 Design of Novel Rho Kinase Inhibitors Using Energy Based Pharmacophore Modeling, Shape-Based Screening, in Silico Virtual Screening, and Biological Evaluation
Ram Kumar Mishra,Reshma Alokam,Sarthak Mohan Singhal,Geethasai Srivathsav,Dharamarajan Sriram,Neerja Kaushik-Basu,Dinesh Manvar,Perumal Yogeeswari
Journal of Chemical Information and Modeling. 2014; 54(10): 2876
[Pubmed]  [Google Scholar] [DOI]
11 Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?
Gustavo Ortiz,Juan P Salica,Eduardo H Chuluyan,Juan E Gallo
Biological Research. 2014; 47(1): 58
[Pubmed]  [Google Scholar] [DOI]
12 The role of proteases and inflammatory molecules in triggering neovascular age-related macular degeneration: basic science to clinical relevance
Sivaraman A. Balasubramanian,Kaavya K. Kumar,Paul N. Baird
Translational Research. 2014;
[Pubmed]  [Google Scholar] [DOI]
13 Enhanced Apoptosis of Monocytes from Complication-Free Juvenile-Onset Diabetes Mellitus Type 1 May Be Ameliorated by TNF-aInhibitors
Jolanta Mysliwska,Monika Ryba-Stanislawowska,Marcin Smardzewski,Bartosz Slominski,Malgorzata Mysliwiec,Janusz Siebert
Mediators of Inflammation. 2014; 2014: 1
[Pubmed]  [Google Scholar] [DOI]
14 Vitrectomy for Diabetic Macular Edema
Bozho Todorich,Tamer H. Mahmoud
Current Ophthalmology Reports. 2014;
[Pubmed]  [Google Scholar] [DOI]
15 Differential systemic gene expression profile in patients with diabetic macular edema: Responders versus nonresponders to standard treatment
Dabir SS, Das D, Nallathambi J, Yadav NK, Schouten JSAG
Indian Journal of Ophthalmology. 2014; 62(1): 66-73
[Pubmed]  [Google Scholar]
16 New treatments for diabetic retinopathy
A. Das,S. Stroud,A. Mehta,S. Rangasamy
Diabetes, Obesity and Metabolism. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
17 Fortified extract of red berry, ginkgo biloba, and white willow bark in experimental early diabetic retinopathy
Bucolo, C. and Marrazzo, G. and Platania, C.B.M. and Drago, F. and Leggio, G.M. and Salomone, S.
Journal of Diabetes Research. 2013; 2013(432695)
[Pubmed]  [Google Scholar]
18 An aqueous extract of Radix Astragali, Angelica sinensis, and Panax notoginseng is effective in preventing diabetic retinopathy
Gao, D. and Guo, Y. and Li, X. and Li, X. and Li, Z. and Xue, M. and Ou, Z. and Liu, M. and Yang, M. and Liu, S. and Yang, S.
Evidence-based Complementary and Alternative Medicine. 2013; 2013(578165)
[Pubmed]  [Google Scholar]
19 Aqueous humor levels of vascular endothelial growth factor and adiponectin in patients with type 2 diabetes before and after intravitreal bevacizumab injection
Costagliola, C. and Daniele, A. and dellæOmo, R. and Romano, M.R. and Aceto, F. and Agnifili, L. and Semeraro, F. and Porcellini, A.
Experimental Eye Research. 2013; 110: 50-54
[Pubmed]  [Google Scholar]
20 Systematic review and meta-analysis of 16 randomized clinical trials of radix astragali and its prescriptions for diabetic retinopathy
Cheng, L. and Zhang, G. and Zhou, Y. and Lu, X. and Zhang, F. and Ye, H. and Duan, J.
Evidence-based Complementary and Alternative Medicine. 2013; 2013(762783)
[Pubmed]  [Google Scholar]
21 Dexamethasoneæs uses in retinal diseases (Chapter )
Smit-McBride Z, Modjtahedi SP, Morse LS
Dexamethasone: Therapeutic Uses, Mechanism of Action and Potential Side Effects. 2013; : 87-116
[Pubmed]  [Google Scholar]
22 ABT-702, an adenosine kinase inhibitor, attenuates inflammation in diabetic retinopathy
Elsherbiny, N.M. and Ahmad, S. and Naime, M. and Elsherbini, A.M. and Fulzele, S. and Al-Gayyar, M.M. and Eissa, L.A. and El-Shishtawy, M.M. and Liou, G.I.
Life Sciences. 2013; 93(2-3): 78-88
[Pubmed]  [Google Scholar]
23 The ERK1/2 inhibitor U0126 attenuates diabetes-induced upregulation of MMP-9 and biomarkers of inflammation in the retina
Mohammad, G. and Mairaj Siddiquei, M. and Imtiaz Nawaz, M. and Abu El-Asrar, A.M.
Journal of Diabetes Research. 2013; 2013(658548)
[Pubmed]  [Google Scholar]
24 Traditional and novel risk factors of diabetic retinopathy and research challenges
Tan GS, IkramMK, Wong TY
Current Medicinal Chemistry. 2013; 20(26): 3189-3199
[Pubmed]  [Google Scholar]
25 Hyperreflective Intraretinal Spots in Diabetics without and with Nonproliferative Diabetic Retinopathy: An In Vivo Study Using Spectral Domain OCT
Stela Vujosevic,Silvia Bini,Giulia Midena,Marianna Berton,Elisabetta Pilotto,Edoardo Midena
Journal of Diabetes Research. 2013; 2013: 1
[Pubmed]  [Google Scholar] [DOI]
26 Fortified Extract of Red Berry, Ginkgo biloba, and White Willow Bark in Experimental Early Diabetic Retinopathy
Claudio Bucolo,Giuseppina Marrazzo,Chiara Bianca Maria Platania,Filippo Drago,Gian Marco Leggio,Salvatore Salomone
Journal of Diabetes Research. 2013; 2013: 1
[Pubmed]  [Google Scholar] [DOI]
27 Aqueous humor levels of vascular endothelial growth factor and adiponectin in patients with type 2 diabetes before and after intravitreal bevacizumab injection
Ciro Costagliola,Aurora Daniele,Roberto dellæOmo,Mario R. Romano,Fabiana Aceto,Luca Agnifili,Francesco Semeraro,Antonio Porcellini
Experimental Eye Research. 2013; 110: 50
[Pubmed]  [Google Scholar] [DOI]
28 An Aqueous Extract of Radix Astragali, Angelica sinensis, and Panax notoginseng Is Effective in Preventing Diabetic Retinopathy
Dehong Gao,Yijuan Guo,Xuejun Li,Xiumin Li,Zhipeng Li,Mei Xue,Zhimin Ou,Ming Liu,Mingxing Yang,Suhuan Liu,Shuyu Yang
Evidence-Based Complementary and Alternative Medicine. 2013; 2013: 1
[Pubmed]  [Google Scholar] [DOI]
29 ABT-702, an adenosine kinase inhibitor, attenuates inflammation in diabetic retinopathy
Nehal M. Elsherbiny,Saif Ahmad,Mohammad Naime,Ahmed M. Elsherbini,Sadanand Fulzele,Mohammed M. Al-Gayyar,Laila A. Eissa,Mamdouh M. El-Shishtawy,Gregory I. Liou
Life Sciences. 2013; 93(2-3): 78
[Pubmed]  [Google Scholar] [DOI]
30 Systematic Review and Meta-Analysis of 16 Randomized Clinical Trials of Radix Astragali and Its Prescriptions for Diabetic Retinopathy
Lin Cheng,Gai Zhang,Yi Zhou,Xuejing Lu,Fuwen Zhang,Hejiang Ye,Junguo Duan
Evidence-Based Complementary and Alternative Medicine. 2013; 2013: 1
[Pubmed]  [Google Scholar] [DOI]
31 Inflammation and Pharmacological Treatment in Diabetic Retinopathy
Snježana Kaštelan,Martina Tomic,Antonela Gverovic Antunica,Jasminka Salopek Rabatic,Spomenka Ljubic
Mediators of Inflammation. 2013; 2013: 1
[Pubmed]  [Google Scholar] [DOI]
32 Analysis of Intraocular Cytokines According to Progression of Diabetic Retinopathy and Macular Edema in Diabetic Patients
Bum Ho Sin,Jin Young Kim,Ji Young Park,Sung Pyo Park
Journal of the Korean Ophthalmological Society. 2013; 54(4): 618
[Pubmed]  [Google Scholar] [DOI]
33 Current Epidemiology of Diabetic Retinopathy and Diabetic Macular Edema
Jie Ding,Tien Yin Wong
Current Diabetes Reports. 2012; 12(4): 346
[Pubmed]  [Google Scholar] [DOI]
34 Role of matrix metalloproteinase-2 and -9 in the development of diabetic retinopathy
Ghulam Mohammad,Mohammad Mairaj Siddiquei
Journal of Ocular Biology, Diseases, and Informatics. 2012; 5(1): 1
[Pubmed]  [Google Scholar] [DOI]
35 Usefulness of the Vitreous Fluid Analysis in the Translational Research of Diabetic Retinopathy
Olga Simó-Servat,Cristina Hernández,Rafael Simó
Mediators of Inflammation. 2012; 2012: 1
[Pubmed]  [Google Scholar] [DOI]
36 Intravitreal autologous plasmin as a therapeutic modality for diffuse diabetic macular edema
Elsawy, M.F.
Clinical Ophthalmology. 2012; 6(1): 2063-2068
[Pubmed]  [Google Scholar]
37 Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathy
Gologorsky, D. and Thanos, A. and Vavvas, D.
Mediators of Inflammation. 2012; 2012(629452)
[Pubmed]  [Google Scholar]
38 Usefulness of the vitreous fluid analysis in the translational research of diabetic retinopathy
Simó-Servat, O. and Hernández, C. and Simó, R.
Mediators of Inflammation. 2012; 2012(872978)
[Pubmed]  [Google Scholar]
39 Pharmacologic induction of heme oxygenase-1 plays a protective role in diabetic retinopathy in rats
Fan, J. and Xu, G. and Jiang, T. and Qin, Y.
Investigative Ophthalmology and Visual Science. 2012; 53(10): 6541-6556
[Pubmed]  [Google Scholar]
40 Current epidemiology of diabetic retinopathy and diabetic macular edema
Ding, J. and Wong, T.Y.
Current Diabetes Reports. 2012; 12(4): 346-354
[Pubmed]  [Google Scholar]
41 Role of matrix metalloproteinase-2 and -9 in the development of diabetic retinopathy
Mohammad, G. and Siddiquei, M.M.
Journal of Ocular Biology, Diseases, and Informatics. 2012; 5(1): 1-8
[Pubmed]  [Google Scholar]
42 Metaloproteazy macierzy zewna{ogonek}trzkomórkowej i ich inhibitory. Udział w rozwoju mikroangiopatii cukrzycowej | [Matrix metalloproteinases and their inhibitors. The role in the development of diabetic microangiopathy]
Kłych A, Kosowska A
Diabetologia Kliniczna. 2012; 1(3): 114-120
[Pubmed]  [Google Scholar]

 

Read this article